Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Endogenous Opioid Modulation by Ketamine


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03051945

Organisation Name: University of Utah

Overal Status: Withdrawn

Start Date: August 2019

Last Update: January 28, 2020

Lead Sponsor: University of Utah

Brief Summary: Demonstrate the acute effects of ketamine on endogenous µ-opioid neurotransmission in humans.

Conditions:
  • Major Depressive Disorder


Total execution time in seconds: 0.50335311889648